Report
found reduced resistance to treatments with some bugs, more resistance among
others
"Our
latest data show some progress in reducing resistance among some germs that
make people sick, but unfortunately we're also seeing greater resistance in
some pathogens, like certain types of salmonella," Dr. Robert Tauxe,
deputy director of the division of foodborne, waterborne and environmental
diseases at the U.S. Centers for Disease Control and Prevention, said in an
agency news release.TUESDAY, July 1, 2014 (HealthDay News) -- There's good news
and bad news about antibiotic resistance among the germs that cause foodborne
illnesses, a new U.S. government report released Tuesday shows.
Each
year, antibiotic-resistant infections from foodborne germs cause about 430,000
illnesses in the United States, according to the CDC.
The
agency's latest data, from 2012, show that multidrug-resistant salmonella,
which causes about 100,000 illnesses a year, decreased during the past 10 years
and resistance to two important types of antibiotics -- cephalosporins and
fluoroquinolones -- remained low.
However,
the rate of resistance to quinolone drugs in Salmonella typhi -- which causes
typhoid fever -- rose to 68 percent in 2012. This means that this class of
drugs, one of the most common treatments for typhoid fever, may no longer be
effective.
The
CDC also said that about 20 percent of Salmonella Heidelberg infections were
resistant to the cephalosporin drug ceftriaxone. S. Heidelberg has been linked
to recent outbreaks of illness associated with poultry.
Ceftriaxone
resistance makes severe salmonella infections harder to treat, especially in
children, the CDC noted.
Among
the other findings:
- Campylobacter resistance to the antibiotic ciprofloxacin remained at 25 percent, despite a 2005 ban on the use of the antibiotic enrofloxacin in poultry. Ciprofloxacin and enrofloxacin are both fluoroquinolone antibiotics.
- Shigella resistance to ciprofloxacin (2 percent) and azithromycin (4 percent) increased, but no strains were resistant to both drugs.
- Resistance to fluoroquinolones remained low. However, 50 percent of infections resistant to the fluoroquinolone drug nalidixic acid were caused by Salmonella enteritidis, the most common salmonella type.
Resistance
to nalidixic acid -- used in laboratory testing for resistance -- is related to
decreased susceptibility to a widely used fluoroquinolone drug ciprofloxacin,
the CDC said in its release.
Many
of the nalidixic acid-resistant Salmonella enteritidis infections among Americans
are acquired when they travel to other countries.
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources